drugset / Trial / NCT07646483

Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and Second Cycle (Repeat) Administration in Patients With Knee Osteoarthritis

NCT07646483

Not yet recruiting 180 enrolled PharmaResearch
RandomizedParallel-groupTriple-blindTreatment

Summary

This clinical trial aims to evaluate and compare the efficacy and safety of Conjuran® and Hyruan in patients with knee osteoarthritis following first and second cycle (repeat) administration.

Timeline

Start
2026-06
Primary completion
2027-09
Completion
2028-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hyaluronic Acid Other / unclassified

Indications